Results 101 to 110 of about 8,517,970 (127)
983 p.This volume presents safety evaluations of selected food contaminants considered by the Joint FAO/WHO Expert Committee on Food Additives (JECFA) at its eighty-third meeting, held in Rome in November 2016.
World Health Organization +1 more
core
Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data. [PDF]
Alorfi NM +13 more
europepmc +1 more source
Joint publication of the Asia-Pacific Network for Global Change Research (APN) and the WHO Centre for Health Development (WHO Kobe Centre)DISASTER, EMERGENCY22 ...
WHO Centre for Health Development (Kobe, Japan)
core
WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-first report
"The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 16 to 20 October 2006"--Introduction156 ...
WHO Expert Committee on Specifications for Pharmaceutical Preparations. Meeting (2006 : Geneva, Switzerland) +1 more
core
WHO Technical Report Series, No. 1061
This report represents the conclusions of the One-hundred-and-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which met at WHO headquarters in Geneva, Switzerland, on 15–21 October 2025 to evaluate the contaminant of ...
WHO; FAO
core
WHO Technical Report Series, 1051
This report represents the conclusions of a Joint FAO/WHO Expert Committee convened to evaluate the safety of various food additives, including flavouring agents, to identify safety concerns and to prepare specifications for the identity and purity of ...
WHO; FAO;
core
463 p.This version of the Guidelines includes an updated recommendation for malaria vaccines, new recommendations on the use of near-patients qualitative and semiquantitative G6PD tests to guide anti-relapse treatment of P. vivax and P.
WHO
core
Global pharmacovigilance analysis of dermatologic toxicity in EGFR-TKI-treated NSCLC: a cross-database real-world study. [PDF]
Sauer N +3 more
europepmc +1 more source
Real‑world safety evaluation of tranexamic acid: Signal detection from FAERS and VigiAccess databases. [PDF]
Feng J, Guo C, Zhao S.
europepmc +1 more source
Safety profile of camrelizumab: An analysis based on literature and database review. [PDF]
Huang Y, Li W.
europepmc +1 more source

